Purpose-fit Capabilities Beyond the breadth of our portfolio across major therapeutic categories, including brands, generics, complex generics (drugdevice combinations and difficult-to-manufacture products) and biosimilars, and the medical, regulatory and legal expertise we possess in the markets we serve, our business model also benefits from a global R&D platform that redefines what it means to innovate.